33.1 Local Anaesthetic Chemistry and Mechanism of Action

Chemical Structure & Classification

All clinically deployed local anaesthetic molecules share an amphiphilic tripartite molecular architecture:

[Lipophilic Aromatic Ring] ──── [Intermediate Hydrocarbon Chain] ──── [Hydrophilic Tertiary Amine]
   (Benzene / Thiophene)             (Ester or Amide Linkage)               (Weak Base Receptor)

1. Lipophilic Aromatic Moiety: Facilitates diffusion across the lipid-rich epineurium, perineurium, and neuronal axonal membrane. In articaine, this aromatic group is a thiophene ring rather than a benzene ring.
2. Intermediate Hydrocarbon Chain: Contains either an ester linkage (-COO-) or an amide linkage (-NHCO-). This intermediate bond classifies the agent and determines its route of biotransformation and elimination.
3. Hydrophilic Amino Group: A tertiary or secondary amine acting as a proton acceptor, existing in dynamic equilibrium between the uncharged tertiary free base and the charged quaternary cation.

                          ┌──────────────────────────────────────────────┐
                          │     Local Anaesthetic Classification         │
                          └──────────────────────┬───────────────────────┘
                                                 │
                     ┌───────────────────────────┴───────────────────────────┐
                     ▼                                                       ▼
          ┌────────────────────┐                                  ┌────────────────────┐
          │    Amide Group     │                                  │    Ester Group     │
          │  (Two 'i's in name)│                                  │   (One 'i' in name)│
          └──────────┬─────────┘                                  └──────────┬─────────┘
                     │                                                       │
         ┌───────────┼───────────┐                               ┌───────────┼───────────┐
         ▼           ▼           ▼                               ▼           ▼           ▼
     Lidocaine   Articaine   Mepivacaine                     Procaine    Benzocaine   Cocaine
     Prilocaine  Bupivacaine                                 Tetracaine

Amides vs. Esters: Metabolic & Immunological Milestones

• Amides (Lidocaine, Articaine, Mepivacaine, Prilocaine, Bupivacaine):

  • Metabolism: Primarily undergo hepatic biotransformation mediated by microsomal cytochrome P450 enzymes (CYP1A2, CYP3A4). Hepatic blood flow and liver function directly govern clearance.
  • Unique Exception: Articaine contains an additional methyl ester side-chain on its thiophene ring. Consequently, 90–95% of articaine is rapidly inactivated by non-specific circulating plasma carboxylesterases (pseudocholinesterases) into inactive articainic acid; only 5–10% undergoes hepatic clearance. This reduces systemic toxicity and confers a very short elimination half-life (~20–40 minutes vs. 90 minutes for lidocaine).
  • Allergenic Potential: Extremely rare. True allergic hypersensitivity is almost exclusively triggered by preservatives in multi-dose vials or vasoconstrictor antioxidants such as sodium metabisulphite, rather than the amide base.

• Esters (Procaine, Benzocaine, Cocaine, Tetracaine):

  • Metabolism: Rapidly hydrolysed in blood plasma by plasma pseudocholinesterase (butyrylcholinesterase).
  • Allergenic Potential: High. Hydrolysis produces para-aminobenzoic acid (PABA), a potent immunological sensitizer associated with allergic dermatitis, bronchospasm, and urticaria. In modern UK dental practice, injectable esters have been entirely superseded by amides, although benzocaine remains in widespread use as a 20% topical surface anaesthetic gel.

| Feature | Amide Anaesthetics | Ester Anaesthetics | |---|---|---|| | Chemical Bond | Amide (-NHCO-) | Ester (-COO-) | | Primary Metabolic Site | Liver microsomal CYP450 (Articaine: 90% plasma) | Plasma pseudocholinesterase | | Major Metabolite | Amines / polar conjugates | Para-aminobenzoic acid (PABA) | | Allergenic Risk | Extremely low (<0.1%) | Moderate to high (PABA hypersensitivity) | | Heat Stability | Extremely stable (can be autoclaved) | Unstable (hydrolyses easily) | | Dental Usage in UK | Universal for local infiltration and nerve blocks | Restricted to topical application (Benzocaine 20%) |

---

Mechanism of Action & Biophysical Principles

Specific Receptor Theory & Channel Blockade

Local anaesthetics act by producing a reversible blockade of voltage-gated sodium channels ($Na_v 1.8, Na_v 1.9, Na_v 1.7$) along the peripheral neuronal axon. Under physiological resting conditions, nerve stimulation triggers channel opening, inward sodium ($Na^+$) influx down its electrochemical gradient, membrane depolarization from $-70\text{ mV}$ to threshold, and propagating action potentials.

Local anaesthetic molecules enter the internal vestibule of the sodium channel pore from the axoplasmic (inner) membrane surface. Binding blocks the passage of $Na^+$ ions, preventing action potential generation and conduction.

Extracellular Interstitial Space (pH 7.4)
     [BH+]  <=========>  [B]  +  [H+]
                           │
   ════════════════════════╪════════════════════════ Nerve Sheath / Axonal Lipid Membrane
                           │ (Un-ionized base diffuses across)
                           ▼
Intracellular Axoplasm (pH 7.1)
     [BH+]  <=========>  [B]  +  [H+]
       │
       ▼
[Binds to inner pore of Voltage-Gated Sodium Channel]
       │
       ▼
[Reversible Sodium Influx Blockade -> Conduction Failure]

Physicochemical Determinants of Clinical Action

1. Dissociation Constant ($pK_a$) & Onset of Action:
   • Local anaesthetics are weak bases prepared commercially as water-soluble hydrochloride salts. In solution, they exist in an equilibrium governed by the Henderson-Hasselbalch equation:

$pH = pK_a + \log\left( \frac{[B]}{[BH^+]} \right)$

• The un-ionized free base ($B$) is lipophilic and is the only form capable of crossing the lipophilic nerve sheath and axonal membrane.
• The protonated cation ($BH^+$) is the pharmacologically active species that binds to the sodium channel receptor on the inner channel pore.
• Agents with a $pK_a$ closest to physiological pH (7.4)—such as Mepivacaine ($pK_a \approx 7.6$), Lidocaine ($pK_a \approx 7.8$), and Articaine ($pK_a \approx 7.8$)—possess a higher proportion of un-ionized base at tissue pH, resulting in rapid membrane permeation and a fast clinical onset (2–4 minutes). Conversely, agents with high $pK_a$ values, such as Bupivacaine ($pK_a \approx 8.1$) or Procaine ($pK_a \approx 9.1$), have very low free base fractions and a delayed onset (5–10 minutes).

1. Lipid Solubility & Intrinsic Potency:

   • Highly lipid-soluble agents (e.g., Bupivacaine, Articaine) penetrate axonal membranes with greater facility, requiring fewer molecules to reach effective intraneuronal concentrations, which confers high intrinsic potency.

2. Protein Binding & Duration of Action:

   • The affinity of the anaesthetic cation for the proteinaceous channel receptor determines the reversibility of the blockade. Agents with high plasma and tissue protein binding (e.g., Bupivacaine ~95%, Articaine ~94%) remain tethered to the sodium channel for extended periods, providing prolonged anaesthetic duration compared to intermediate binders (Lidocaine ~65%, Prilocaine ~55%).

The Acidic/Inflamed Tissue Conundrum

When dental infection or purulent inflammation is present (e.g., periapical abscess), the local extracellular tissue pH drops markedly from physiological 7.4 down to 5.5–6.0 due to bacterial acidic metabolites and cellular lysis.

Applying the Henderson-Hasselbalch equation demonstrates that under acidic conditions, the equilibrium shifts dramatically to the left:

$\downarrow pH \longrightarrow \uparrow [H^+] \longrightarrow \uparrow [BH^+] \text{ (Charged Cation)} \quad \& \quad \downarrow [B] \text{ (Free Base)}$

With virtually no lipophilic un-ionized free base available to diffuse through the epineurium, local anaesthetic deposited directly into inflamed tissue fails to penetrate nerve fibres, resulting in severe anaesthetic failure. Furthermore, localized inflammatory hyperaemia increases vascular clearance of the injected solution.

[!TIP] Overcoming Local Anaesthetic Failure in Infection:

• Administer regional nerve blocks (e.g., Inferior Alveolar Nerve Block, Mental/Incisive Block, or Maxillary Nerve Block) well proximal to the site of tissue inflammation, where tissue pH is normal (7.4).
• Utilize supplemental techniques such as intraligamentary, intraosseous, or intrapulpal injections under pressure.
• Avoid infiltrating directly into active cellulitis or purulence, which risks spreading the infection into adjacent facial spaces.

---